Related Experiment Video
Updated: Feb 2, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Patterns of proton therapy use in pediatric cancer management in 2016: An international survey
Neige Journy1, Daniel J Indelicato2, Diana R Withrow3
1INSERM U1018, Centre for Research in Epidemiology and Population Health, Cancer & Radiations Group, Gustave Roussy Cancer Campus, Villejuif, France.
Insights
This study surveyed proton therapy use in pediatric cancer patients worldwide. While CNS tumors remain common, extra-cranial tumors are increasing, highlighting the need for global research on proton therapy outcomes.
Area of Science:
- Oncology
- Radiotherapy
- Pediatric Medicine
Background:
- Proton therapy offers advanced radiation treatment for pediatric cancers.
- Understanding current global usage patterns is crucial for future research on long-term effects.
- Late effects of proton therapy in children require further investigation.
Purpose of the Study:
- To assess worldwide patterns of proton therapy utilization in patients under 22 years old.
- To establish a baseline for observational studies on the late effects of proton therapy in pediatric cancer survivors.
- To gather data on patient demographics, tumor types, and treatment techniques.
Main Methods:
- A global survey was conducted in 2016, inviting 54 proton therapy centers treating pediatric patients.
- Data collected included patient numbers by age group, treatment intent, delivery technique, and tumor types.
- Forty centers participated, representing a 74% response rate across 11 countries.
Main Results:
- 1,860 pediatric patients received proton therapy in 2016 across North America, Europe, and Asia.
- The majority of patients were under 10 years old, with Central Nervous System (CNS) tumors being the most frequent diagnosis.
- Pencil beam scanning was used in approximately half of the treatments, and treatment patterns were similar across continents.
Conclusions:
- This is the first global assessment of proton therapy use in pediatric cancer.
- Central Nervous System (CNS) tumors are still the primary indication, but extra-cranial tumors are increasingly treated.
- Low patient numbers per center emphasize the necessity of international research collaborations to evaluate long-term proton therapy outcomes in children.
Purpose:
To facilitate the initiation of observational studies on late effects of proton therapy in pediatric patients, we report on current patterns of proton therapy use worldwide in patients aged less than 22 years.
Materials & Methods:
Fifty-four proton centers treating pediatric patients in 2016 in 11 countries were invited to respond to a survey about the number of patients treated during that year by age group, intent of treatment, delivery technique and tumor types.
Results:
Among the 40 participating centers (participation rate: 74%), a total of 1,860 patients were treated in 2016 (North America: 1205, Europe: 432, Asia: 223). The numbers of patients per center ranged from 1 to 206 (median: 29). Twenty-four percent of the patients were <5 years of age, and 50% <10 years. More than 30 pediatric tumor types were identified, mainly treated with curative intent: 48% were CNS, 25% extra-cranial sarcomas, 7% neuroblastoma, and 5% hematopoietic tumors. About half of the patients were treated with pencil beam scanning. Treatment patterns were broadly similar across the three continents.
Conclusion:
To our knowledge, this survey provides the first worldwide assessment of proton therapy use for pediatric cancer management. Since previous estimates in the United States and Europe, CNS tumors remain the cancer types most commonly treated with protons in 2016. However, the proportion of extra-cranial tumors is growing worldwide. The typically low numbers of patients treated in each center indicate the need for international research collaborations to assess long-term outcomes of proton therapy in pediatric patients.
Related Concept Videos
Surveys
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Introduction to Surveying, Plane Surveying and Geodetic Surveys
Internal Energy
Errors and Mistakes in Surveying

